The Envision Pro will be factory-calibrated, disposable, and is intended for use by health care professionals.
Senseonics continues to make inroads in its rollout of the Eversense CGM.
An overview of insulin pump therapy, with Diabetes Care and Education Specialist Ashlee Ernst.
How the founder of Integrated Medical Sensors was motivated to develop better blood sugar monitoring options by his mother’s diabetes diagnosis.
Dexcom officials shared this news and more details about its pipeline of diabetes technology in a recent earnings call.
Presenters, including members of the T1D Exchange Quality Improvement Collaborative, discussed ways to raise awareness of the upside of CGM use among the patient population.
Here are four articles about five studies presented at the annual conference on everything from fear of hypoglycemia to lost sleep from blood sugar management.
The medical device maker is hoping to keep costs down and increase access to its novel glucose monitoring device.
The results of the WISDM study, recently presented at the ADA’s 79th Scientific Sessions, examined the effectiveness of wearing CGMs versus blood glucose monitors on hypoglycemia.
T1D Exchange Glu sat down with the president and CEO of Dexcom to discuss his company’s plans and the future of continuous glucose monitoring.
Already a Member?
This pioneering effort provides a mobile-friendly platform for people throughout the U.S. to participate online and share information about their type 1 diabetes